Scipher Medicine snaps up $82m

Scipher Medicine, a precision immunology company, has secured $82 million in Series C financing.

Scipher Medicine, a precision immunology company, has secured $82 million in Series C financing. The lead backers were aMoon and Northpond Ventures.

Source: Press Release